CDKN2A and cancer: Various TSGs are silenced in cancer cells by promoter hypermethylation such as RB1, H1C1 (Hypermethylated In Cancer 1), p16INK4A, MLH1 (Human Mutant L homologue 1), BRCA1 (BReast CAncer 1) and p73 [17-23].